Bacteriostatic Characteristics of Bone Substituting Constructors Obtained from Composite Materials Based on Natural Polymers, Calcium Phosphates and Vancomycin

Abstract


Introduction. The local delivery of therapeutic antibiotic concentrations to the zone of surgical intervention in bone pathology enables either to prevent or significantly decrease the rate of osteomyelitis development. It that study the efficacy of vancomycin inclusion and release from three dimensional constructors based on sodium alginate, gelatin and octacalcium phosphate and vancomycin intended for bone defect substitution was studied. Materials and methods . Prototyping of 3D constructors was performed by extrusion 3D printing. Various concentrations of vancomycin were added as an additional component at the stage of preparation of hydrogel (“ink”) for printing. Physical testing of the constructors included electron microscopic evaluation of their microstructure and porosity as well as the study of mechanical strength for compression and stretching. Functional activity of printed constructors with respect to the test strain S. aureus ATCC 6538-P was assessed by a disc-diffusion method in vitro and on the model of infected excision skin wound in rats - in vivo. Results . Analysis of the kinetic curves showed that the principal release of the drug in the model liquid took place within the first day. The total volume of the bound and released vancomycin made up approximately 20% of the calculated initial amount for all three concentrations. Formation of the marked growth inhibition zone of S. aureus strain in presence of vancomycin rich constructors was demonstrated in vitro. Insertion of constructors into the zone of infected skin defect resulted in a decrease of inflammatory processes severity and rate as well as accelerated the terms of complete wound healing. Conclusion. Study results showed the principle potentiality of bone substituting implants 3D-printing using multicomponent hydrogel compositions without change of separate components characteristics.

Full Text

Restricted Access

About the authors

P. A Karalkin

P.A. Herzen Moscow Oncology Research Institute

Email: prognoz.06@mail.ru
Moscow, Russia
cand. med. sci., senior research worker, department of conservative treatment efficacy prognosis, MNIOI named after P.A. Gertsen - branch of NMIRTs

N. S Sergeeva

Pirogov Russian National Research Medical University

Moscow, Russia

V. S Komlev

A. Baikov Institute of Metallurgy and Materials Science

Moscow, Russia

I. K Sviridova

P.A. Herzen Moscow Oncology Research Institute

Moscow, Russia

V. A Kirsanova

P.A. Herzen Moscow Oncology Research Institute

Moscow, Russia

S. A Akhmedova

P.A. Herzen Moscow Oncology Research Institute

Moscow, Russia

Ya. D Shanskiy

P.A. Herzen Moscow Oncology Research Institute

Moscow, Russia

E. A Kuvshinova

P.A. Herzen Moscow Oncology Research Institute

Moscow, Russia

A. Yu Fedotov

A. Baikov Institute of Metallurgy and Materials Science

Moscow, Russia

A. Yu Teterina

A. Baikov Institute of Metallurgy and Materials Science

Moscow, Russia

S. M Barinov

A. Baikov Institute of Metallurgy and Materials Science

Moscow, Russia

A. D Kaprin

P.A. Herzen Moscow Oncology Research Institute

Moscow, Russia

References

  1. Lew D.P., Waldvogel F.A. Osteomyelitis. Lancet. 2004; 364 (9431): 369-79. doi: 10.1016/S0140-6736(04)16727-5.
  2. Jorge L.S., Chueire A.G., Rossit A.R. Osteomyelitis: a current challenge. Braz. J. Infect. Dis. 2010; 14 (3): 310-5.
  3. Treaba D., Assad L., Govil H. et al. Diagnostic role of fine- needle aspiration of bone lesions in patients with a previous history of malignancy. Diagn. Cytopathol. 2002; 26 (6): 380-3. doi: 10.1002/dc.10120.
  4. Seng P., Alliez A., Honnorat E. et al. Osteomyelitis of sternum and rib after breast prosthesis implantation. IDCases. 2014; 2 (1): 31-3. doi: 10.1016/j.idcr.2014.12.004.
  5. Olson M.E., Horswill A.R. Staphylococcus aureus osteomyelitis: bad to the bone. Cell Host Microbe. 2013; 13 (6): 629-31. doi: 10.1016/j.chom.2013.05.015.
  6. Trampuz A., Widmer A.F. Infections associated with orthopedic implants. Curr. Opin. Infect. Dis. 2006; 19 (4): 349-56. doi: 10.1097/01.qco.0000235161.85925.e8.
  7. Marculescu C.E., Berbari E.F., Cockerill F.R., Osmon D.R. Fungi, mycobacteria, zoonotic and other organisms in prosthetic joint infection. Clin. Orthop. Relat. Res. 2006; 451: 64-72. doi: 10.1097/01.blo.0000229337.21653.f2.
  8. Gogia J.S., Meehan J.P., Di Cesare P.E., Jamali A.A. Local antibiotic therapy in osteomyelitis. Semin. Plast. Surg. 2009; 23 (2): 100-7. doi: 10.1055/s-0029-1214162.
  9. Панкратов А.С., Лекишвили М.В., Копецкий И.С. Костная пластика в стоматологии и челюстно-лицевой хирургии. Остеопластические материалы. М.: БИНОМ; 2011: 120-38.
  10. Pertici G., Carinci F., Carusi G. et al. Composite polymer- coated mineral scaffolds for bone regeneration: from material characterization to human studies. J. Biol. Regul. Homeost. Agents. 2015; 29 (3 Suppl. 1): 136-48.
  11. Сергеева Н.С., Комлев В.С., Свиридова И.К. и др. Некоторые физико-химические и биологические характеристики трехмерных конструкций на основе альгината натрия и фосфатов кальция, полученных методом 3D-печати и предназначенных для реконструкции костных дефектов. Гены и клетки. 2015; 10 (2): 39-45.
  12. Komlev V.S., Barinov S.M., Bozo I.I., Deev R.V., Eremin I.I., Sergeeva N.S. et al. Bioceramics composed of octacalcium phosphate demonstrate enhanced biological behavior. ACS Appl. Mater. Interfaces. 2014; 6 (19): 16610-20.
  13. Каралкин П.А., Сергеева Н.С., Комлев В.С. и др. Биосовместимость и остеопластические свойства минерал-полимерных композиционных материалов на основе альгината натрия, желатина и фосфатов кальция, предназначенных для трехмерной печати костно-замещающих конструкций. Гены и клетки. 2016; 11 (3): 94-101.
  14. Inzana J.A., Trombetta R.P., Schwarz E.M. et al. 3D printed bioceramics for dual antibiotic delivery to treat implant-associated bone infection. Eur. Cell. Mater. 2015; 4 (30): 232-47.
  15. Bose S., Vahabzadeh S., Bandyopadhyay A. Bone Tissue Engineering Using 3D Printing. Materials Today. 2013; 16: 496-504. doi: 10.1016/j.mattod.2013.11.017.
  16. Kim H.W., Knowles J.C., Kim H.E. Porous scaffolds of gelatin-hydroxyapatite nanocomposites obtained by biomimetic approach: characterization and antibiotic drug release. J. Biomed. Mater. Res. B Appl. Biomater. 2005; 74 (2): 686-98. doi: 10.1002/jbm.b.30236.
  17. Costa P.F. Bone Tissue Engineering Drug Delivery. Curr. Mol. Bio Rep. 2015; 1: 87-93. doi: 10.1007/s40610-015- 0016-0.
  18. Melicherc_k P., Jahoda D., Nyc O. et al. Bone grafts as vancomycin carriers in local therapy of resistant infections. Folia Microbiol. (Praha). 2012; 57(5): 459-62.
  19. Hernandez F.J., Hernandez L.I., Kavruk M. et al. NanoKeepers: stimuli responsive nanocapsules for programmed specific targeting and drug delivery. Chem. Commun. (Camb). 2014; 50 (67): 9489-92. doi: 10.1039/ c4cc04248d.
  20. Methods for the determination of susceptibility of bacteria to antimicrobial agents. EUCAST Definitive document. Clin. Microbiol. Infect. 1998; 4: 291-96.
  21. Tack P., Victor J., Gemmel P., Annemans L. 3D-printing techniques in a medical setting: a systematic literature review. Biomed. Eng. Online. 2016; 15 (1): 115. doi: 10.1186/s12938-016-0236-4.
  22. Suzuki O., Imaizumi H., Kamakura S., Katagiri T. Bone regeneration by synthetic octacalcium phosphate and its role in biological mineralization. Curr. Med. Chem. 2008; 15 (3): 305-13.
  23. Polo-Corrales L., Latorre-Esteves M., Ramirez-Vick J.E. Scaffold design for bone regeneration. J. Nanosci. Nanotechnol. 2014; 14 (1): 15-56.
  24. Tozzi G., De Mori A., Oliveira A., Roldo M. Composite Hydrogels for Bone Regeneration. Materials. 2016; 9 (4): 267-91. doi: 10.3390/ma9040267.
  25. Inzana J.A., Olvera D., Fuller S.M. et al. 3D printing of composite calcium phosphate and collagen scaffolds for bone regeneration. Biomaterials. 2014; 35 (13): 4026-34. doi: 10.1016/j.biomaterials.2014.01.064.
  26. Inzana J.A., Schwarz E.M., Kates S.L., Awad H.A. Biomaterials approaches to treating implant-associated osteomyelitis. Biomaterials. 2016; 81: 58-71. doi: 10.1016/j. biomaterials.2015.12.012.
  27. Reizner W., Hunter J.G., O’Malley N.T. et al. A systematic review of animal models for Staphylococcus aureus osteomyelitis. Eur. Cell. Mater. 2014; 27: 196-212.

Statistics

Views

Abstract - 27

Cited-By


Article Metrics

Metrics Loading ...

Refbacks

  • There are currently no refbacks.

Copyright (c) 2017 Karalkin P.A., Sergeeva N.S., Komlev V.S., Sviridova I.K., Kirsanova V.A., Akhmedova S.A., Shanskiy Y.D., Kuvshinova E.A., Fedotov A.Y., Teterina A.Y., Barinov S.M., Kaprin A.D.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies